Latest Developments in the Treatment of Pulmonary Arterial Hypertension

0 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Guest: Robert P. Frantz, M.D.
Host: Kyle Klarich, M.D.

Overview:
Pulmonary arterial hypertension (PAH) is a serious disease manifested by vasoconstriction and obliteration of the pulmonary arterial vasculature resulting in rise in pulmonary artery pressure and resistance and culminating in right heart failure. Listeners will learn more about traditional treatments for PAH, as well as new anti-proliferative therapies in active clinical investigation, and what that means for the future of treatment.

Topics Discussed:
• What is most new and exciting in the treatment of pulmonary arterial hypertension?
• What monitoring is necessary in order to safely use sotatercept?
• What future developments do you envision for the field of pulmonary hypertension?

From Mayo Clinic to your inbox, sign-up for free: https://mayocl.in/3e71zfi

Visit Mayo Clinic: https://mayocl.in/2COVmlm

Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Category
Cardiology
Be the first to comment

Up Next